From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

Welcome to Journal Watch. The content you requested requires sign in with a username and password.

The Evaluation and Management of Dyslipidemia in HIV-Infected Patients

A metabolic syndrome of insulin resistance, obesity, hypertension, and dyslipidemia is quite common and is a significant risk factor for CHD. HIV-treatment-associated fat-redistribution syndrome with dyslipidemia is similar in appearance to this "metabolic syndrome" observed in non-HIV-infected people. Thus, it is important to review the epidemiology, pathogenesis, diagnosis, and management of HIV-treatment-associated dyslipidemia to alert clinicians and patients about this emerging problem.

Sign In

Forgot your password?

If you do not use cookies, sign in here.

Don't yet have a username or password?

Register now for

Journal Watch e-mail alerts and unlimited online access to articles 6 months after publication. register

Subscribe now for

Full, immediate online access to all Journal Watch content and services. subscribe

Already a subscriber? Activate your subscription to receive full online access.

Get full site access with a 7-day site pass for $19

Copyright © 2001. Massachusetts Medical Society. All rights reserved.